Merck & Co., Inc. Payments to Acquire Marketable Securities
Merck & Co., Inc. (MRK) reported Payments to Acquire Marketable Securities of $587.00 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2023-08-07
- Merck & Co., Inc. payments to acquire marketable securities for the quarter ending 2023-06-30 was $25.00M, a 92.49% decline year-over-year.
- Merck & Co., Inc. payments to acquire marketable securities for the quarter ending 2023-03-31 was $562.00M, a 51.08% increase year-over-year.
- Merck & Co., Inc. payments to acquire marketable securities for the quarter ending 2022-12-31 was $494.00M.
- Merck & Co., Inc. payments to acquire marketable securities for the quarter ending 2022-09-30 was $5.00M.
- Merck & Co., Inc. payments to acquire marketable securities for fiscal 2022 was $1.20B, a 120300.00% increase from fiscal 2021.
- Merck & Co., Inc. payments to acquire marketable securities for fiscal 2021 was $1.00M, a 98.95% decline from fiscal 2020.
- Merck & Co., Inc. payments to acquire marketable securities for fiscal 2020 was $95.00M, a 97.03% decline from fiscal 2019.
- Merck & Co., Inc. payments to acquire marketable securities for fiscal 2019 was $3.20B, a 59.94% decline from fiscal 2018.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2023-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $587.00M 10-Q · filed 2023-08-07 | $1.08B derived: sum of 3 quarters · filed 2023-08-07 | $1.09B derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | $562.00M 10-Q · filed 2023-05-05 | $1.06B derived: sum of 2 quarters · filed 2023-05-05 | $1.06B derived: sum of 3 quarters · filed 2023-05-05 | $1.39B derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-12-31 | $494.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $499.00M derived: sum of 2 quarters · filed 2023-02-24 | $832.00M derived: sum of 3 quarters · filed 2023-08-07 | $1.20B 10-K · filed 2023-02-24 |
| 2022-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $338.00M derived: sum of 2 quarters · filed 2023-08-07 | $710.00M 10-Q · filed 2022-11-03 | $710.00M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-06-30 | $333.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $705.00M 10-Q · filed 2023-08-07 | $705.00M derived: sum of 3 quarters · filed 2023-08-07 | $705.00M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $372.00M 10-Q · filed 2023-05-05 | $372.00M derived: sum of 2 quarters · filed 2023-05-05 | $372.00M derived: sum of 3 quarters · filed 2023-05-05 | $372.00M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $1.00M 10-K · filed 2023-02-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $1.00M 10-Q · filed 2022-11-03 | $18.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.00M 10-Q · filed 2022-08-05 | $18.00M derived: sum of 3 quarters · filed 2023-02-24 | $19.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $1.00M 10-Q · filed 2022-05-05 | $18.00M derived: sum of 2 quarters · filed 2023-02-24 | $19.00M derived: sum of 3 quarters · filed 2023-02-24 | $47.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $18.00M derived: sum of 2 quarters · filed 2023-02-24 | $46.00M derived: sum of 3 quarters · filed 2023-02-24 | $95.00M 10-K · filed 2023-02-24 |
| 2020-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $29.00M derived: sum of 2 quarters · filed 2021-11-05 | $78.00M 10-Q · filed 2021-11-05 | $900.00M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $77.00M 10-Q · filed 2021-08-09 | $899.00M derived: sum of 3 quarters · filed 2022-02-25 | $1.47B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $49.00M 10-Q · filed 2021-05-05 | $871.00M derived: sum of 2 quarters · filed 2022-02-25 | $1.44B derived: sum of 3 quarters · filed 2022-02-25 | $2.28B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $822.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.39B derived: sum of 2 quarters · filed 2022-02-25 | $2.23B derived: sum of 3 quarters · filed 2022-02-25 | $3.20B 10-K · filed 2022-02-25 |
| 2019-09-30 | $570.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.41B derived: sum of 2 quarters · filed 2020-11-05 | $2.38B 10-Q · filed 2020-11-05 | $3.48B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $836.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.81B 10-Q · filed 2020-08-05 | $2.90B derived: sum of 3 quarters · filed 2021-02-25 | $4.56B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $974.00M 10-Q · filed 2020-05-06 | $2.07B derived: sum of 2 quarters · filed 2021-02-25 | $3.72B derived: sum of 3 quarters · filed 2021-02-25 | $7.64B derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.75B derived: sum of 2 quarters · filed 2021-02-25 | $6.67B derived: sum of 3 quarters · filed 2021-02-25 | $7.99B 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.65B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.57B derived: sum of 2 quarters · filed 2019-11-05 | $6.90B 10-Q · filed 2019-11-05 | $9.24B derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $3.92B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.25B 10-Q · filed 2019-08-06 | $7.59B derived: sum of 3 quarters · filed 2020-02-26 | $9.71B derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $1.33B 10-Q · filed 2019-05-08 | $3.67B derived: sum of 2 quarters · filed 2020-02-26 | $5.79B derived: sum of 3 quarters · filed 2020-02-26 | $9.14B derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $2.34B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $4.46B derived: sum of 2 quarters · filed 2020-02-26 | $7.81B derived: sum of 3 quarters · filed 2020-02-26 | $10.74B 10-K · filed 2020-02-26 |
| 2017-09-30 | $2.12B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $5.47B derived: sum of 2 quarters · filed 2018-11-06 | $8.40B 10-Q · filed 2018-11-06 | $13.96B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $3.35B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.28B 10-Q · filed 2018-08-07 | $11.85B derived: sum of 3 quarters · filed 2019-02-27 | $15.58B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $2.93B 10-Q · filed 2018-05-08 | $8.50B derived: sum of 2 quarters · filed 2019-02-27 | $12.22B derived: sum of 3 quarters · filed 2019-02-27 | $16.21B derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $5.57B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $9.30B derived: sum of 2 quarters · filed 2019-02-27 | $13.28B derived: sum of 3 quarters · filed 2019-02-27 | $15.65B 10-K · filed 2019-02-27 |
| 2016-09-30 | $3.73B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.72B derived: sum of 2 quarters · filed 2017-11-07 | $10.08B 10-Q · filed 2017-11-07 | $14.34B derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $3.99B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.36B 10-Q · filed 2017-08-08 | $10.61B derived: sum of 3 quarters · filed 2018-02-27 | $14.41B derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $2.37B 10-Q · filed 2017-05-09 | $6.62B derived: sum of 2 quarters · filed 2018-02-27 | $10.43B derived: sum of 3 quarters · filed 2018-02-27 | $14.01B derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $4.26B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $8.06B derived: sum of 2 quarters · filed 2018-02-27 | $11.64B derived: sum of 3 quarters · filed 2018-02-27 | $16.68B 10-K · filed 2018-02-27 |
| 2015-09-30 | $3.80B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $7.39B derived: sum of 2 quarters · filed 2016-11-07 | $12.43B 10-Q · filed 2016-11-07 | $21.14B derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $3.58B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $8.62B 10-Q · filed 2016-08-08 | $17.33B derived: sum of 3 quarters · filed 2017-02-28 | $21.18B derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $5.04B 10-Q · filed 2016-05-09 | $13.75B derived: sum of 2 quarters · filed 2017-02-28 | $17.60B derived: sum of 3 quarters · filed 2017-02-28 | $23.16B derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $8.71B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $12.56B derived: sum of 2 quarters · filed 2017-02-28 | $18.12B derived: sum of 3 quarters · filed 2017-02-28 | $24.94B 10-K · filed 2017-02-28 |
| 2014-09-30 | $3.85B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $9.41B derived: sum of 2 quarters · filed 2015-11-05 | $16.23B 10-Q · filed 2015-11-05 | $21.14B derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $5.55B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $12.38B 10-Q · filed 2015-08-06 | $17.29B derived: sum of 3 quarters · filed 2016-02-26 | $21.55B derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $6.83B 10-Q · filed 2015-05-07 | $11.74B derived: sum of 2 quarters · filed 2016-02-26 | $16.00B derived: sum of 3 quarters · filed 2016-02-26 | $20.81B derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $4.91B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $9.17B derived: sum of 2 quarters · filed 2016-02-26 | $13.98B derived: sum of 3 quarters · filed 2016-02-26 | $17.99B 10-K · filed 2016-02-26 |
| 2013-09-30 | $4.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $9.07B derived: sum of 2 quarters · filed 2014-11-10 | $13.08B 10-Q · filed 2014-11-10 | $19.03B derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $4.81B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $8.82B 10-Q · filed 2014-08-07 | $14.77B derived: sum of 3 quarters · filed 2015-02-27 | $17.66B derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $4.01B 10-Q · filed 2014-05-08 | $9.96B derived: sum of 2 quarters · filed 2015-02-27 | $12.85B derived: sum of 3 quarters · filed 2015-02-27 | $14.13B derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $5.95B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.84B derived: sum of 2 quarters · filed 2015-02-27 | $10.12B derived: sum of 3 quarters · filed 2015-02-27 | $12.84B 10-K · filed 2015-02-27 |
| 2012-09-30 | $2.89B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $4.17B derived: sum of 2 quarters · filed 2013-11-07 | $6.89B 10-Q · filed 2013-11-07 | $9.53B derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $1.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $4.00B 10-Q · filed 2013-08-07 | $6.64B derived: sum of 3 quarters · filed 2014-02-27 | $8.26B derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $2.73B 10-Q · filed 2013-05-09 | $5.36B derived: sum of 2 quarters · filed 2014-02-27 | $6.98B derived: sum of 3 quarters · filed 2014-02-27 | $8.67B derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $2.64B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $4.26B derived: sum of 2 quarters · filed 2014-02-27 | $5.94B derived: sum of 3 quarters · filed 2014-02-27 | $7.33B 10-K · filed 2014-02-27 |
| 2011-09-30 | $1.62B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $3.30B derived: sum of 2 quarters · filed 2012-11-09 | $4.69B 10-Q · filed 2012-11-09 | $6.06B derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $1.68B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $3.07B 10-Q · filed 2012-08-07 | $4.44B derived: sum of 3 quarters · filed 2013-02-28 | $6.03B derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $1.38B 10-Q · filed 2012-05-08 | $2.75B derived: sum of 2 quarters · filed 2013-02-28 | $4.34B derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | $1.37B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.96B derived: sum of 2 quarters · filed 2013-02-28 | $7.20B 10-K · filed 2013-02-28 | |
| 2010-09-30 | $1.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $5.83B 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $4.24B 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $3.07B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |